Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application
Authors
Keywords
Hepatocellular carcinoma, Emagliflozin/metformin, Autophagy, Apoptosis, Angiogenesis, Metastasis
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 145, Issue -, Pages 112455
Publisher
Elsevier BV
Online
2021-11-26
DOI
10.1016/j.biopha.2021.112455
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Distinct functions of transforming growth factor-β signaling in c-MYC driven hepatocellular carcinoma initiation and progression
- (2021) Haichuan Wang et al. Cell Death & Disease
- Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- (2021) Haleh Chehrehgosha et al. Diabetes Therapy
- BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats
- (2021) Sameh Saber et al. LIFE SCIENCES
- Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NFκB/AMPK/NLRP3 axis
- (2021) Magdy Abou El-Rous et al. INFLAMMOPHARMACOLOGY
- Decoding empagliflozin’s molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence
- (2021) Antoni Bayes-Genis et al. Scientific Reports
- Interference With the AMPKα/mTOR/NLRP3 Signaling and the IL-23/IL-17 Axis Effectively Protects Against the Dextran Sulfate Sodium Intoxication in Rats: A New Paradigm in Empagliflozin and Metformin Reprofiling for the Management of Ulcerative Colitis
- (2021) Mahmoud E. Youssef et al. Frontiers in Pharmacology
- Albendazole-loaded cubosomes interrupt the ERK1/2-HIF-1α-p300/CREB axis in mice intoxicated with diethylnitrosamine: A new paradigm in drug repurposing for the inhibition of hepatocellular carcinoma progression
- (2021) Sameh Saber et al. BIOMEDICINE & PHARMACOTHERAPY
- Telmisartan alleviates alcohol-induced liver injury by activation of PPAR-γ/ Nrf-2 crosstalk in mice
- (2021) Amir Mohamed Abdelhamid et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Targeting CD166+ lung cancer stem cells: Molecular study using murine dendritic cell vaccine
- (2021) N.E. El-Ashmawy et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The Changing Epidemiology of Hepatocellular Carcinoma : Experience of a Single Center
- (2020) Lydia Giannitrapani et al. Biomed Research International
- Epidemiology of Hepatocellular Carcinoma
- (2020) Katherine A. McGlynn et al. HEPATOLOGY
- Celastrol augments sensitivity of NLRP3 to CP-456773 by modulating HSP-90 and inducing autophagy in dextran sodium sulphate-induced colitis in rats
- (2020) Sameh Saber et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Reduced IκBα promotes hepatocellular carcinoma cell proliferation and migration via regulation of NF‑κB/Erbin axis
- (2020) Ye Tan et al. Oncology Letters
- An SGLT2 inhibitor modulates SHH expression by activating AMPK to inhibit the migration and induce the apoptosis of cervical carcinoma cells
- (2020) Zipeng Xie et al. CANCER LETTERS
- Immunosuppressive role of Benzo[a]pyrene in induction of lung cancer in mice
- (2020) Mohamed L. Salem et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The interactions between mTOR and NF‐κB: A novel mechanism mediating mechanical stretch‐stimulated osteoblast differentiation
- (2020) Dan Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Dietary intake of genistein suppresses hepatocellular carcinoma through AMPK-mediated apoptosis and anti-inflammation
- (2019) Sang R. Lee et al. BMC CANCER
- Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma
- (2019) Lena Schulte et al. LIVER INTERNATIONAL
- SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
- (2019) Chenguang Li et al. Cardiovascular Diabetology
- Diabetes is Associated with Increased Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
- (2019) Ju Dong Yang et al. HEPATOLOGY
- Telmisartan attenuates N-nitrosodiethylamine-induced hepatocellular carcinoma in mice by modulating the NF-κB-TAK1-ERK1/2 axis in the context of PPARγ agonistic activity
- (2019) Sameh Saber et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Metformin Regulates the Expression of CD133 Through the AMPK-CEBPβ Pathway in Hepatocellular Carcinoma Cell Lines
- (2019) Osamu Maehara et al. NEOPLASIA
- SGLT-2 (Sodium-Glucose Cotransporter 2) Inhibition Reduces Ang II (Angiotensin II)–Induced Dissecting Abdominal Aortic Aneurysm in ApoE (Apolipoprotein E) Knockout Mice
- (2019) Rebeca Ortega et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Apoptosis induction and ERK/NF‐κB inactivation are associated with magnolol‐inhibited tumor progression in hepatocellular carcinoma in vivo
- (2019) Jai‐Jen Tsai et al. ENVIRONMENTAL TOXICOLOGY
- The SGLT2 Inhibitor Empagliflozin Ameliorates the Inflammatory Profile in Type 2 Diabetic Patients and Promotes an Antioxidant Response in Leukocytes
- (2019) Francesca Iannantuoni et al. Journal of Clinical Medicine
- Empagliflozin attenuates ischemia and reperfusion injury through LKB1/AMPK signaling pathway
- (2019) Qingguo Lu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition
- (2019) Nitin A. Das et al. CELLULAR SIGNALLING
- Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events
- (2018) Toshiaki Ohkuma et al. DIABETOLOGIA
- Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies
- (2018) Tracey G. Simon et al. HEPATOLOGY
- Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
- (2018) Lorenza Rimassa et al. LANCET ONCOLOGY
- Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-κB pathway
- (2018) Xu Chen et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission
- (2018) Hao Zhou et al. Redox Biology
- Sitagliptin attenuates myocardial apoptosis via activating LKB-1/AMPK/Akt pathway and suppressing the activity of GSK-3β and p38α/MAPK in a rat model of diabetic cardiomyopathy
- (2018) Nouf T. Al-Damry et al. BIOMEDICINE & PHARMACOTHERAPY
- Effects of metformin on the PI3K/AKT/FOXO1 pathway in anaplastic thyroid Cancer cell lines
- (2018) Zahra Nozhat et al. DARU-Journal of Pharmaceutical Sciences
- Metformin is associated with reduced cell proliferation in human endometrial cancer by inbibiting PI3K/AKT/mTOR signaling
- (2017) Yan Zhao et al. GYNECOLOGICAL ENDOCRINOLOGY
- TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α
- (2017) Anahita Hamidi et al. Science Signaling
- Sitagliptin attenuates high glucose-induced alterations in migration, proliferation, calcification and apoptosis of vascular smooth muscle cells through ERK1/2 signal pathway
- (2017) Lili Shi et al. Oncotarget
- TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α
- (2017) Anahita Hamidi et al. Science Signaling
- The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma
- (2017) Dou-Sheng Bai et al. Scientific Reports
- Sorafenib effect on liver neoplastic changes in rats: more than a kinase inhibitor
- (2016) Nahla E. El-Ashmawy et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Initial Combination of Empagliflozin and Metformin in Patients With Type 2 Diabetes
- (2016) Samy Hadjadj et al. DIABETES CARE
- Effect of Pomegranate Hull Extract on Liver Neoplastic Changes in Rats: More than an Antioxidant
- (2016) Nahla E. El-Ashmawy et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
- (2016) H. K. Sanoff et al. ONCOLOGIST
- The Role of Metformin in Controlling Oxidative Stress in Muscle of Diabetic Rats
- (2016) Danielle Diniz Vilela et al. Oxidative Medicine and Cellular Longevity
- A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-κB regulates head and neck squamous cell carcinoma proliferation
- (2016) Zhipeng Li et al. Oncotarget
- Spotlight on empagliflozin/metformin fixed-dose combination for the treatment of type 2 diabetes: a systematic review
- (2016) Vijay Shivaswamy et al. Patient Preference and Adherence
- The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic β-Cell Mass and Glucose Homeostasis in Type 1 Diabetes
- (2016) Sam Tsz Wai Cheng et al. PLoS One
- Evaluation of Effects of Metformin in Primary Ovarian Cancer Cells
- (2015) Seema Patel et al. Asian Pacific Journal of Cancer Prevention
- AMPK Activation Inhibits Expression of Proinflammatory Mediators Through Downregulation of PI3K/p38 MAPK and NF-κB Signaling in Murine Macrophages
- (2015) Bee-Piao Huang et al. DNA AND CELL BIOLOGY
- Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial
- (2015) Calin Cainap et al. JOURNAL OF CLINICAL ONCOLOGY
- Transforming Growth Factor-Beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer Progression
- (2015) Jelena Krstić et al. Oxidative Medicine and Cellular Longevity
- Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway
- (2015) Baiyu Han et al. TUMOR BIOLOGY
- Targeting AMPK for cancer prevention and treatment
- (2015) Weidong Li et al. Oncotarget
- A dual role for the anti-apoptotic Bcl-2 protein in cancer: Mitochondria versus endoplasmic reticulum
- (2014) Haidar Akl et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
- (2014) Andrew X. Zhu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The morbidity and associated risk factors of cancer in chronic liver disease patients with diabetes mellitus: a multicenter field survey
- (2014) Takumi Kawaguchi et al. JOURNAL OF GASTROENTEROLOGY
- Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection
- (2014) Stephen M. Hatfield et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Curcumin ameliorate DENA-induced HCC via modulating TGF-β, AKT, and caspase-3 expression in experimental rat model
- (2014) Mekky M. M. Abouzied et al. TUMOR BIOLOGY
- Prognostic Significance of AMPK Activation and Therapeutic Effects of Metformin in Hepatocellular Carcinoma
- (2013) L. Zheng et al. CLINICAL CANCER RESEARCH
- Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
- (2013) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial
- (2013) Ann-Lii Cheng et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of metformin on the proliferation, migration, and MMP-2 and -9 expression of human umbilical vein endothelial cells
- (2012) NILUFAR ESFAHANIAN et al. Molecular Medicine Reports
- Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis
- (2012) Hui Zhang et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The role of hypoxia inducible factor-1α in the increased MMP-2 and MMP-9 production by human monocytes exposed to nickel nanoparticles
- (2011) Rong Wan et al. Nanotoxicology
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
- (2011) Joungmok Kim et al. NATURE CELL BIOLOGY
- The Role of Pre-Existing Diabetes Mellitus on Hepatocellular Carcinoma Occurrence and Prognosis: A Meta-Analysis of Prospective Cohort Studies
- (2011) Wan-Shui Yang et al. PLoS One
- Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism
- (2010) Smitha V. Bava et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Thymoquinone Attenuates Diethylnitrosamine Induction of Hepatic Carcinogenesis Through Antioxidant Signaling
- (2010) Mohamed M. Sayed-Ahmed et al. Oxidative Medicine and Cellular Longevity
- Autophagy genes as tumor suppressors
- (2009) Chengyu Liang et al. CURRENT OPINION IN CELL BIOLOGY
- Experimental mouse models for hepatocellular carcinoma research
- (2009) Femke Heindryckx et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
- Anti-apoptotic effect of transforming growth factor-β1 on human articular chondrocytes: role of protein phosphatase 2A
- (2008) M. Lires-Deán et al. OSTEOARTHRITIS AND CARTILAGE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now